| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |